New once a month pill for osteoporosis

Boniva, a once a month pill for osteoporosis, has won Food and Drug Administration approval, according to the Wall Street Journal. Existing products must be taken at least weekly.

Introducing more convenient dosing is a popular strategy. It provides real benefits to consumers by making it easier to stay on the medication. This is especially true for bisphosphonates such as Boniva and Merck’s Fosamax, because the patient needs to remain upright for 30-60 minutes following administration. It’s also good for drug companies, because it often enables them to extend an existing, proven compound and charge the same amount per patient per year despite selling fewer pills. This is less risky and costly than developing a new compound and helps stave off generic competition.

Boniva breaks new ground by being the first oral treatment for any chronic condition that is taken as infrequently as once a month. Usually, achieving such a dosing interval has required injection. In fact, Novartis is working on a once a year injection for osteoporosis.

Roche Holding developed the drug and it will be marketed by GlaxoSmithKline.

March 28, 2005

5 thoughts on “New once a month pill for osteoporosis”

  1. Just tried Boniva (free pill from Roche). When I tried to refill for next month, I was told that Highmark BC/BS isn’t covering it. What a waste of money to advertise on primetime TV something that out of pocket costs $80/pill. Who is going to use it if the insurance won’t pay for it!!

  2. It is not my first time to visit this web page, i am browsing this site dailly and obtain pleasant
    information from here every day.

Leave a Reply

Your email address will not be published. Required fields are marked *